Impact of TP53 Mutation Status in Elderly AML Patients When Adding All‐Trans Retinoic Acid or Valproic Acid to Decitabine.

Saved in:
Bibliographic Details
Title: Impact of TP53 Mutation Status in Elderly AML Patients When Adding All‐Trans Retinoic Acid or Valproic Acid to Decitabine.
Authors: Bresser, Helena1 (AUTHOR), Schmoor, Claudia2 (AUTHOR), Grishina, Olga2 (AUTHOR), Pfeifer, Dietmar1 (AUTHOR), Thomas, Johanna1 (AUTHOR), Rehman, Usama‐Ur1 (AUTHOR), Crysandt, Martina3 (AUTHOR), Jost, Edgar3 (AUTHOR), Thol, Felicitas4 (AUTHOR), Heuser, Michael4 (AUTHOR), Götze, Katharina S.5,6 (AUTHOR), Schlenk, Richard F.7,8 (AUTHOR), Salih, Helmut R.9 (AUTHOR), Schittenhelm, Marcus M.9,10 (AUTHOR), Heil, Gerhard11 (AUTHOR), Schwaenen, Carsten12 (AUTHOR), Müller‐Tidow, Carsten7,13 (AUTHOR), Brugger, Wolfram14 (AUTHOR), Kündgen, Andrea15,16 (AUTHOR), de Wit, Maike17 (AUTHOR)
Source: European Journal of Haematology. Feb2025, Vol. 114 Issue 2, p231-237. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09024441
DOI:10.1111/ejh.14304